GILD
Price:
$93.395
Market Cap:
$116.40B
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, an injection for intravenous use, for the treatment of coronavirus disease 2019; and Epclusa, Harvoni, Vosevi, Vemlidy, and Viread for the treatment of liver diseases. It also offers Yescarta, Tecartus, Trodelvy, and Zydelig products for the treatment of hematology, oncology, and cell therapy patients. In addition, the company provides Letairis, an ora...[Read more]
Industry
Drug Manufacturers - General
IPO Date
1992-01-22
Stock Exchange
NASDAQ
Ticker
GILD
According to Gilead Sciences, Inc.’s latest financial reports and current stock price. The company's current ROE is 0.65%. This represents a change of -238.99% compared to the average of -0.47% of the last 4 quarters.
The mean historical ROE of Gilead Sciences, Inc. over the last ten years is 38.92%. The current 0.65% ROE has changed -98.32% with respect to the historical average. Over the past ten years (40 quarters), GILD's ROE was at its highest in in the June 2015 quarter at 27.00%. The ROE was at its lowest in in the March 2024 quarter at -23.78%.
Average
38.92%
Median
25.07%
Minimum
0.49%
Maximum
94.74%
Discovering the peaks and valleys of Gilead Sciences, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 5.95%
Maximum Annual ROE = 94.74%
Minimum Annual Increase = -97.95%
Minimum Annual ROE = 0.49%
Year | ROE | Change |
---|---|---|
2023 | 24.81% | 14.59% |
2022 | 21.65% | -26.74% |
2021 | 29.55% | 5.95% |
2020 | 0.49% | -97.95% |
2019 | 23.78% | -6.13% |
2018 | 25.33% | 12.22% |
2017 | 22.57% | -67.62% |
2016 | 69.73% | -26.40% |
2015 | 94.74% | 23.85% |
2014 | 76.50% | 192.19% |
The current ROE of Gilead Sciences, Inc. (GILD) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
25.34%
5-year avg
20.06%
10-year avg
38.92%
Gilead Sciences, Inc.’s ROE is less than Amgen Inc. (68.49%), less than Merck & Co., Inc. (29.27%), less than AbbVie Inc. (65.72%), less than Johnson & Johnson (20.94%), greater than Bristol-Myers Squibb Company (-36.26%), less than Pfizer Inc. (4.72%), less than Eli Lilly and Company (65.15%), less than AstraZeneca PLC (16.57%),
Company | ROE | Market cap |
---|---|---|
68.49% | $147.04B | |
29.27% | $262.72B | |
65.72% | $310.70B | |
20.94% | $358.83B | |
-36.26% | $119.59B | |
4.72% | $145.19B | |
65.15% | $782.09B | |
16.57% | $209.09B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Gilead Sciences, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Gilead Sciences, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Gilead Sciences, Inc.'s ROE?
How is the ROE calculated for Gilead Sciences, Inc. (GILD)?
What is the highest ROE for Gilead Sciences, Inc. (GILD)?
What is the 3-year average ROE for Gilead Sciences, Inc. (GILD)?
What is the 5-year average ROE for Gilead Sciences, Inc. (GILD)?
How does the current ROE for Gilead Sciences, Inc. (GILD) compare to its historical average?